The new full visual range IOL enables 93% of patients to become free from glasses at all distances. With best-in-class image contrast and low-light performance, TECNIS Odyssey IOL expands the Johnson & Johnson portfolio of advanced Presbyopia-Correcting IOLs. TECNIS Odyssey IOL enables surgeons to deliver consistent and reliable
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision. Johnson & Johnson, a global leader in eye health, announced today that its TECNIS PureSee™ purely refractive intraocular lens (IOL) for individuals with presbyopia is now available in India. The TECNIS PureSee™ IOL features a
In a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has directed Johnson & Johnson Limited to pay Rs 35 lakh to a consumer who experienced medical complications due to a faulty hip replacement device. The commission, comprising presiding member Ram Surat Maurya and
To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform About 20 lakh new cancer cases were reported in India last year, while the actual occurrence is considered to 1.5 to 3 times higher, states a
South Africa has started giving COVID-19 vaccinations to adolescents aged between 12 and 17 years, with a goal of inoculating at least 6 million people from this age group. The country is trying to increase its rate of vaccinations which is running behind the target of
The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N), and said Americans can choose a different shot from their original inoculation as a booster. That means all three vaccines authorized in
